uk-50001

CAS No. 857900-47-1

uk-50001( —— )

Catalog No. M36004 CAS No. 857900-47-1

uk-50001 is a phosphodiesterase (PDE) 4 inhibitor that can be used for many diseases, especially inflammation, allergies, respiratory diseases, disorders and conditions and wounds.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 246 Get Quote
5MG 380 Get Quote
10MG 570 Get Quote
25MG 882 Get Quote
50MG 1178 Get Quote
100MG 1575 Get Quote
500MG 3141 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    uk-50001
  • Note
    Research use only, not for human use.
  • Brief Description
    uk-50001 is a phosphodiesterase (PDE) 4 inhibitor that can be used for many diseases, especially inflammation, allergies, respiratory diseases, disorders and conditions and wounds.
  • Description
    uk-50001 is a phosphodiesterase (PDE) 4 inhibitor that can be used for many diseases, especially inflammation, allergies, respiratory diseases, disorders and conditions and wounds.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Angiogenesis
  • Target
    PDE
  • Recptor
    PDE
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    857900-47-1
  • Formula Weight
    499.48
  • Molecular Formula
    C26H24F3N3O4
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O(C1=C(C(NC2CCC(NC(=O)C3=C(O)C=CC(C)=C3)CC2)=O)C=C(F)C=N1)C4=CC(F)=C(F)C=C4
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Thioquinapiperifil d...

    Thioquinapiperifil dihydrochloride is a phosphodiesterase (PDE-5) inhibitor (IC50: 0.074 nM) that is potent, selective and non-competitive for investigational maturation.

  • ITI214 free base

    ITI-214 is a potent, selective phosphodiesterase 1 (PDE1) inhibitor with Ki of 58 pM.

  • Enoximone

    Enoximone is a selective inhibitor of phosphodiesterase III (PDE3), with treatment of congestive heart failure.